Category: Heel Pharmacological Index

Galega officinalis-Injeel
D 10, D 30, D 200 0.367 ml each.

To stimulate diuresis and promote milk secretion; diabetes mellitus.

Musculi oculi suis-Injeel
(muscle of the eye)

Strabismus, condition after apoplexy with opthalmoplegia.

Plumbum jodatum-Injeel
D 12, D 30, D 200 0.367 ml each.

Muscular atrophy, atonic paresis, arteriosclerosis, myomas.

Contraindications

In case of thyroid disorders, this preparation may not be administered without prior approval from a physician.

Bacterium pyocyaneus-Injeel
D 12, D 30, D 200 0.367 ml each.
Bacterium pyocyaneus-Injeel forte
D 6, D 12, D 30, D 200 0.275 ml each.

Symptoms or (delayed) sequelae after the following diseases:

inflammation of the bile duct and urinary passages, otitis media, dermal gangrene (ecthyma gangraenosum), puerperal sepsis. Hyperhidrosis, impregnation phases after retoxically arrested sudation; after the misuse of purgatives (as mixed injections with Senna-Injeel forte) and in angina tonsillaris.

Acidum DL-malicum-Injeel
D 10, D 30, D 200 0.367 ml each.
Acidum-DL-malicum-Injeel forte
D 6, D 10, D 30, D 200 0.275 ml each.

Cactus-Injeel
D 12, D 30, D 200 0.367 ml each.
Cactus-Injeel forte
D 3, D 6, D 12, D 30, D 200 0.220 ml each.

Stenocardia (sensation of constriction of the heart); palpitations day and night, rushes of blood to the head, flushing of the face).

Acidum p-aminosalicylicum-Injeel
D 10, D 30, D 200 0.367 ml each.

This tuberculostatic, also known as PAS, can cause, in addition to allergic reactions, also gastro-intestinal disturbances, liver damage and disturbances of the haematopoiesis as well as cardiogenic and nephrogenic excretory disorders. Further, a feeling of heat may also occur after the administration of PAS. Hypothyreosis and crystalluria with a corresponding transmineralization are also included in the range of therapeutical damage or side effects, as also the occurrence of lupus erythematosus (L.E.).

Indications

The above-mentioned diseases as therapeutical damage or side effects after the administration of PAS.

Carcinoma mammae-Injeel
D 10, D 30, D 200 0.367 ml each.
Carcinoma mammae-Injeel forte
D 6, D 10, D 30, D 200 0.275 ml each.

For auxiliary/additional therapy in carcinoma of the breast (also, and in particular, post-operatively as well as after irradiation). Further, in mastopathia chronica cystica, mastitis cystica, cystic mamma, diffuse fibromatosis, etc.

Muira puama-Injeel
D 8, D 12, D 30, D 200 0.275 ml each.
Muira puama-Injeel forte
D 4, D 8, D 12, D 30, D 200 0.220 ml each.

Aphrodisiac; to tone the central nervous system.

Dystrophia musculorum progressiva-Nosode-Injeel
D 12, D 30, D 200 0.367 ml each.
Dystrophia musculorum progressiva-Nosode-Injeel forte
D 8, D 12, D 30, D 200 0.275 ml each.

Chronic degenerative diseases in the region of the transversely striped musculature, independently of type (atrophy, pseudohypertrophy: pathological increase of connective tissue and adipose tissue within the anatomically altered, functionally disturbed muscles) and location.